Envista Holdings, the dental spin-off of Danaher, raised almost $590 million from an initial public offering completed September 18.
The company sold nearly 27 million shares at $22 a share on the first day it was available. Shares closed at just under $28 per share, up 27%.
Envista is the parent company of KaVo Kerr, Nobel Biocare, and Ormco.
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
